| Market revenue in 2025 | USD 370.2 million |
| Market revenue in 2033 | USD 653.8 million |
| Growth rate | 7.4% (CAGR from 2026 to 2033) |
| Largest segment | Immunoassay |
| Fastest growing segment | Molecular Diagnostics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunoassay, Molecular Diagnostics |
| Key market players worldwide | BD, Roche, Hologic Inc, Abbott Laboratories, Danaher Corp, Qiagen NV, OraSure Technologies Inc, Bio-Rad Laboratories Inc, BioMerieux SA, Thermo Fisher Scientific Inc, Seegene, Diasorin SpA |
Growing number of laboratories and favorable government policies are among factors expected to boost market growth during the forecast period. However, positive results decreased nationwide and in Île-de-France in 2018, but stayed consistent elsewhere.
In the country, HIV testing activity at centers for free information, testing, and diagnosis (CeGIDDs) has remained consistent (322,000 tests in 2018). Similarly, community-based testing employing rapid HIV tests (TROD) was found to be steady among highrisk populations.
Approximately 65,000 of these tests were performed in 2018. In addition, the sales of self-testing products were relatively stable between 2016 and 2018 (74,000 tests sold in 2018), before picking up in 2019 with the introduction of a more affordable option (79,500 tests sold in 2019).
Publish Date: Jun 18, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Diasorin SpA | View profile | 3,233 | Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 | www.diasoringroup.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | www.roche.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to STD Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Immunoassay was the largest segment with a revenue share of 47.22% in 2025.
Horizon Databook has segmented the France std diagnostics market based on immunoassay, molecular diagnostics covering the revenue growth of each sub-segment from 2021 to 2033.
Growing number of laboratories and favorable government policies are among factors expected to boost market growth during the forecast period. However, positive results decreased nationwide and in Île-de-France in 2018, but stayed consistent elsewhere.
In the country, HIV testing activity at centers for free information, testing, and diagnosis (CeGIDDs) has remained consistent (322,000 tests in 2018). Similarly, community-based testing employing rapid HIV tests (TROD) was found to be steady among highrisk populations.
Approximately 65,000 of these tests were performed in 2018. In addition, the sales of self-testing products were relatively stable between 2016 and 2018 (74,000 tests sold in 2018), before picking up in 2019 with the introduction of a more affordable option (79,500 tests sold in 2019).
Horizon Databook provides a detailed overview of country-level data and insights on the France STD Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into France STD Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
